Cross-reactive carbohydrate determinants of plants are essentially a mixture of Nglycans containing β1,2-xylose and core α1,3-fucose, the latter being also found in insect glycoproteins. In order to determine the relative contributions of these two sugar residues to antibody binding we have prepared an array of glycomodified forms of human apo-transferrin. Using core-α1,3-fucosyltransferase (EC 2.4.1.214) and β1,2-xylosyltransferase (EC 2.4.2.38) recombinantly expressed in Pichia pastoris and suitable glycosidases, glycoforms containing either only fucose (MMF), only xylose (MMX), both (MMXF) or none of them (MM) linked to the common pentasaccharide core were generated. Additional glycoforms were obtained by enzymatic removal of the α1,3-linked mannosyl residue. These transferrin glycoforms served to define the binding specificity of antibodies in Western blot, ELISA and inhibition ELISA.
Introduction
With regard to glycosylation, plants may appear as a fairly uninventive group since their glycoproteins carry the same limited set of structures almost regardless of the species (Lerouge et al., 1998; Wilson et al., 2001) . However, just because of this and because some of the structural details are foreign to and hence immunogenic in mammals, plant N-glycans probably constitute the most frequently occuring set of epitopes to which we are exposed (Wilson et al., 1998a) . The vast potential for crossreaction of antibodies with carbohydrate determinants is further extended by the occurrence of the same epitope structures on glycoproteins of insects, molluscs and parasitic worms (Wilson et al., 1998a; Lommerse et al., 1997; Altmann et al., 1999; Wilson, 2002) . In detail, plant N-glycans carry a fucose residue in α1,3-linkage to the innermost GlcNAc (Ishihara et al., 1979; Lerouge et al., 1998) and this immunogenic feature also occurs on insect glycoproteins Altmann et al., 1999) and even on N-glycans from Schistosoma and Haemonchus (Van Die et al., 1999; Haslam et al., 2001; Faveeuw et al., 2003) . In addition, a xylose residue, never seen in mammalian N-glycans, is present on plant N-glycans (Ishihara et al., 1979; Lerouge et al., 1998) but again, this feature is found in invertebrate animals such as snails (van Kuik et al., 1985) and parasitic trematodes (Haslam et al., 2001; Faveeuw et al., 2003) .
More than 20 years ago, the existence of a cross-reactive carbohydrate determinant (CCD) was proposed based on the promiscuous binding of allergic patients` sera to periodate sensitive, heat stable epitopes in a variety of allergens (Aalberse et al., 1981) . While these criteria might well have been misleading, the hypothesis was later confirmed by increasingly more sophisticated experiments. In 1988, a similarly crossreactive rabbit antiserum was described (Faye and Chrispeels, 1988) and in 1991 antihorseradish peroxidase serum was shown to bind to complex type plant N-glycans containing xylose and core α1,3-fucose (Kurosaka et al., 1991) .
Not much later, Tretter et al. (1993) reported that, due to the presence of core α1,3-fucose, plant N-glycans can bind IgE from many bee venom allergic patients. In this and in other studies bromelain glycopeptides were employed and the relative lability of the α1,3-fucosyl linkage allowed the preparation of non-fucosylated glycopeptides, which could be tested in antibody-binding assays. As these defucosylated glycopeptides -still containing xylose -were unable to bind IgE from bee venom allergic individuals we concluded that the core α1,3-fucose is the key structural element for antibody binding. Identical results were obtained with patients sensitized against tomato, celery and other allergens (Petersen et al., 1996 , Fötisch et al., 1999 , Fötisch et al., 2001 . However, other important allergens such as Ara h 1, Ole e 1 or a vicillin-like 48 kDa protein from hazelnut, to which anti-CCD IgE binds, have been found to contain primarily structures with only xylose Altmann, 2000¸ van Ree et al., 2000; Müller et al., 2000) . Strong evidence in favor or the assumption that xylose also plays a role as (part of) a glyco-epitope came from a report on the fractionation of a polyclonal anti-horseradish peroxidase antiserum into a fucose specific and a xylose specific pool using immobilized honeybee phospholipase (Faye et al., 1993) . Unfortunately there was no well-defined glycoprotein containing xylose only that would have helped to assess the specificity of these fractions or the specificity of patients` sera IgE. Ascorbic acid oxidase from zucchini, occasionally used for that purpose (Batanero et al., 1999) , definitely also contains fucose (Altmann, 1998) whereas not necessarily all of the -partially very complex -structures occuring on hemocyanin from Helix pomatia have so far been elucidated (Lommerse et al., 1997) .
Thus, while it is clear that the term "cross-reacting carbohydrate determinants" essentially means complex type plant N-glycans (Foetisch and Vieths, 2001) , the relative contributions of fucose and xylose or of other structural features to antibody binding are still unclear. Likewise, a sometimes postulated supportive role of the protein backbone for antibody binding has never been proven or disproven.
The biological significance of carbohydrate determinants in food, insect venom or pollen allergies, however, is to a much higher degree unclear and topic of a current debate (van der Veen et al., 1997; Foetisch and Vieths, 2001; Foetisch et al., 2003; Hemmer et al., 2001) . In many cases, anti-CCD IgE antibodies do not appear to trigger clinical symptoms (van Ree et al., 1997; van Ree, 2002) . This is contrasted by positive histamine release tests with some patients` sera (Foetisch et al., 1999; Foetisch et al., 2003; Westphal et al., 2003; Bublin et al., 2003) and by cases of patients with symptoms elicited by foods in the absence of detectable amounts of IgE against peptide epitopes . The various aspects associated with carbohydrate determinants as allergens, e.g. the discrepancies between serum tests, histamine release, skin tests and finally clinical symptoms have recently been reviewed and need not to be recapitulated here (van Ree, 2002) . Clearly, CCDs play a role as a source of "false" positive serum test results in allergy diagnosis as the presence of anti-CCD IgE often has no clinical consequences (Mari et al., 1999; Hemmer et al., 2001; van Ree, 2002; Hemmer et al., submitted) . In keeping with earlier reports Foetisch et al., 1999) , a recent survey indicated 23 % out of 1,831 patients have anti-CCD IgE (Mari, 2002) . The criterion for CCDreactivity was a positive ELISA and a negative skin prick test against bromelain -a plant glycoprotein with one complex type N-glycan lacking the α1,3-mannose (Ishihara et al., 1979) . While this report impressively demonstrates the dimension of the problem, it also demonstrates the need for structurally defined and more easily applicable test antigens for the detection of anti-glycan IgE antibodies.
Here we report on the synthesis and characterisation of a glyco-modified human glycoprotein. Various glycoforms of human transferrin with or without xylose, fucose, terminal GlcNAc or 3-linked mannose have been prepared (Fig. 1) and their ability to bind anti-CCD IgG and anti-CCD IgE from patients` sera was tested.
RESULTS

Glyco-modification of human transferrin
Human transferrin (Tf) carries two N-glycans which are mainly disialylated and diantennary with only a small fraction being triantennary (Spik et al., 1985) . It therefore has a comparatively homogeneous glycosylation and it can be easily converted into a substrate for transferases requiring non-reducing terminal GlcNAc such as Fuc-T and Xyl-T by the use of sialidase and galactosidase. This GnGn-Tf was now subject to incubations with either Fuc-T or Xyl-T which were recombinantly expressed in Pichia pastoris as recently reported (Bencúrová et al., 2003) . While Xyl-T had been purified to homogeneity by Ni-chelate chromatography, Fuc-T was unstable under such conditions and hence untagged Fuc-T was enriched by dyeaffinity chromatography.
Both Xyl-T and Fuc-T could be obtained in a form concentrated enough to allow an essentially complete conversion of several mg of GnGn-Tf to GnGnX-Tf or GnGnFTf, respectively ( Figs. 1 and 2 ). Initially, we had problems to achieve complete fucosylation and speculations were made as to a restricted access of the transferase to the attachment on the native transferrin. However, the problem could be overcome by adding aliquots of the donor sugar GDP-fucose over the course of incubation and, thus, the incomplete conversion was due the instability of GDP-fucose rather than a decreasing activity of the enzyme. Although the Pichia strain used (GS115) secretes detectable amounts of protease (Brierly, 1998) the final products were essentially intact with only a small amount of a fragment band at 41.3 kDa (Fig. 4D ).
To make sure that in following experiments any observed antibody binding could be exclusively attributed to the glycan moieties of Tf, the transferase incubation mixtures were done in duplicate, one with and one without the donor sugars UDP-xylose or GDP-fucose. However, as later described, there was absolutely no binding of anti-HRP and several patients` sera to these controls. Thus we believe that in future it will not be necessary to add Fuc-T or Xyl-T in the absence of the relevant nucleotide sugar in order to prepare MM-Tf from GnGn-Tf. An aliquot of the fucosylated GnGnF-Tf was subsequently xylosylated to yield GnGnXF-Tf.
Recent reports would suggest that the N-glycans recognised by anti-CCD did not contain terminal GlcNAc (Wilson et al., 1998a; van Ree et al., 2000; Foetisch and Vieths, 2001) . In addition, preliminary results of anti-HRP Western blots with fucosylated and xylosylated forms of GnGn-transferrin with or without prior hexosaminidase indicated that in fact the terminal GlcNAc residues had a weakening effect on antibody binding. Therefore, the primary transferase products were digested with hexosaminidase to finally yield the glyco-variants MM-, MMX-, MMF-and MMXF-Tf. The success of the various modification steps was finally verified by mass spectrometry of the glycopeptides around Asn 630 (Fig. 3) . The glycopeptide 421-433
could not be observed in the MALDI spectrum. It should be noted that the glycosidases used (except the α-mannosidase) were not of plant origin, thus avoiding any "glyco-contamination" from this source.
Specificity of two rabbit antisera and a rat monoclonal antibody
With optimized amounts of fully converted transferrin and optimized dilutions of antiserum binding to GnGnF-Tf could not be observed (Fig. 4A ). An inhibition experiment confirmed the attenuating effect of terminal GlcNAc residues (Table 1) and thus the further study was conducted with MMF-, MMX-and MMXF-Tf. We could not detect any cross-reactions of the sera with components from the expression system despite thorough controls, e.g. by making transferase incubations without or with the "wrong" nucleotide sugar.
A Western blot with MMX-and MMF-Tf revealed specific anti-HRP binding to both new glyco-epitopes (Fig. 4A ). This is in keeping with a report on fractionation by immobilized bee venom phospholipase of anti-HRP serum into a fucose-and a xylose specific fraction (Faye et al., 1993) . Anti-bee venom serum showed binding to MMFTf as well as to MMXF-Tf, but not to MMX-Tf (Fig. 4B ). This result reflects the absence of xylose in honeybee venom Kubelka et al., 1995; Kolarich and Altmann 2000 ).
An ELISA titration of anti-HRP using MMX-, MMF-, and MMXF-transferrin as antigens revealed strikingly similar antibody titers against each of the three glycoforms. This could imply that this serum consists of one population of antibodies which although polyclonal all bind with similar affinity to each of the three glycoforms. However, subsequent inhibition studies revealed the opposite. Binding of anti-HRP to MMX-Tf could not be inhibited by MMF-Tf and binding to MMF-Tf not by MMX-Tf (Table 1) . In contrast binding of the rat monoclonal antibody YZ1/2.23 to MMX-Tf and MMF-Tf could be mutually cross-inhibited by MMX-and MMF-Tf (Table 1) . Noteworthy, the absorbance measured for binding to MMX-Tf was only half that obtained with MMF-Tf. Apparently, YZ1/2.23 bears a paratope that covers both the fucosyl and the xylosyl residues, but with fucose contributing more to binding strength. Thus, YZ1/2.23 cannot be used to discriminate between fucosylated or xylosylated glycoproteins (Fig. 4C ).
In previous work, defucosylation of bromelain glycopeptides led to a drastic decrease in their antibody binding capacity indicating negligible antibody binding by the glycopeptide carrying solely xylose Petersen et al., 1996; Wilson et al., 1998a) . The data presented here appear to contradict these earlier reports, as binding to MMX-Tf was displayed by both anti-HRP and YZ1/2.23 ( Fig. 4 and Table   1 ). However, in the previous studies, defucosylated bromelain, which has a MUX structure, was used. Comparison of the inhibitory potency of MMX and MUX for anti-HRP binding to MMX-Tf revealed the significance of the α1,3-mannosyl residue (Table 1 and also Fig. 4) . In other words: while the MUXF structure of bromelain glycopeptides is suitable for measuring "anti-fucose" antibodies (Wilson et al., 1998a) it does not appear to be useful for detecting "anti-xylose" antibodies.
Up to that point, only transferrin glycoforms had been used as coat antigens. A natural glycoprotein might contain additional structural features and thus we chose oil seed rape pollen extract as more natural example to explore the "natural history" of anti-CCD antibodies. Essentially complete inhibition of anti-HRP binding to oil seed rape pollen could be obtained by MMXF-Tf at a concentration ranging from 1 to 100 µg / mL (table 1). HRP itself however inhibited more effectively on a weight per volume basis by at factor of about 30 to 60 (Table 1 ). Considering at least 7 N-glycans per molecule of HRP with a mass of 45 kDa for HRP and 1.6 fucosylated glycans per molecule of transferrin with a mass of 70 kDa, the difference shrinks, in molar terms, to between 4 and 9. This still significant difference in inhibitory potency could point to a contribution to antibody binding of the peptide regions in the neighbourhood of the N-glycan which of course differ between transferrin and HRP to which the antibody was actually raised. It could, however, simply reflect the difference in valency of these two glycoproteins which is known to be a critical factor for binding strength of carbohydrate epitopes (Welply et al., 1994; Yi et al., 1998) . Finally it should be mentioned that GnGnXF-Tf had only negligible inhibitory potency for anti-HRP (Table 1) .
Detection and characterization of IgE against cross-reactive carbohydrate determinants (CCDs)
Finally, a small panel of allergic patients` sera was subject to measurement of specific IgE binding to the different transferrin glycoforms. All of the bee and wasp venom double positive patients` sera showed reaction with the fucosylated transferrins MMF and MMXF (the latter, however, could not be tested with all sera). Many sera of this group gave especially high readings in ELISA (Fig. 5A) . Similarly, most of the rape pollen reactive sera also reacted with MMF and MMXF which corroborates the recent conclusion that oilseed rape pollen reactivity is in many cases due to anti-CCD IgE whereby rape pollen itself had not necessarily been the elicitor of this immune response (Hemmer et al., 2001) . None of the sera in these groups bound with MMX.
In the case of the insect venom allergic patients this is not surprising. However, also these sera bound stronger to MMXF-transferrin which was, in addition to being fucosylated, also xylosylated (Fig. 5B) .
None of the 20 sera from patients monosensitized to birch pollen reacted with any of the glycan-modified transferrins (data not shown), whereas four of the 24 sera from patients monosensitized to grass pollen reacted with MMF-Tf and/or MMXF-Tf. The highest prevalence of anti-CCD IgE was found in the sera from patients with multiple pollen allergy with at least 10 out of the 41 sera (24%) being positive (Fig. 5C ).
To our surprise and disappointment, none of the sera recognized MMX to a significant degree with the exception of one heavily atopic patient whose serum reacted strongly even with MM-Tf. As this contrasts the results obtained for rabbit anti-HRP, we assume the lack of MMX-binding by human IgE to be the result of our serum selection rather than of a general "invisibility" of xylose for the human immune system. This is especially obvious for the insect venom group as insect glycoproteins do not contain xylose. Future studies with panels of patients allergic against primarily xylosylated allergens such as olive pollen, hazelnut or peanut may clarify this point.
Recently, human IgG levels against CCD structures have been measured using honeybee venom phospholipase and Helix pomatia hemocyanin as core α1,3-fucosylated probe and as β1,2-xylosylated standards, respectively (Bardor et al., 2002) . We compared the results obtained with the glycomodified transferrins with these naturally available probes. The results obtained with phospholipase and MMFor MMXF-transferrin indeed were in agreement. The ELISA readings, however, were generally lower with phospholipase with the exception of a few sera where especially high values for phospholipase suggested the presence of anti-protein IgE (Fig. 6A) . In other words, since the phospholipase polypeptide is the major allergen of bee venom, it cannot at all be regarded as a reliable probe for the measurement of anti-CCD antibodies. Hemocyanin, like MMX-Tf, was not bound significantly by any of the sera (data not shown).
DISCUSSION
Using the divalent human glycoprotein transferrin and recombinant glycosyltransferases, it was possible for the first time to generate and study plant glyco-epitopes containing either only fucose or only xylose rather than the usual mixture. In contrast to the use of naturally occuring glycoproteins such as phospholipase A 2 from honeybee venom (MMF and other structures), hemocyanin from H. pomatia (MMX and many undefined structures), ascorbic oxidase (erroneously supposed to contain only MMX; Altmann, 1998) or chemically defucosylated bromelain glycopeptides (Wilson et al., 1998a) (MUX with possibly some residual MUXF), the approach presented in this paper allows the comparison of defined glycoforms all linked to the same carrier protein that had been subject to defined steps of modification. Hence, stringent controls can be introduced, e.g. by omission of the nucleotide sugar in the preparation scheme. While the influence of substitution of the terminal mannose residues by GlcNAc could be studied using GnGnF-and GnGnX-Tf, no natural glycoprotein with a complete substitution of the mannoses is known. Furthermore, degradation of MMX to MUX by mannosidase can be achieved on the whole protein.
As the glycans on human transferrin, especially in the GnGn, but also in the galactosylated form, are substrate for a variety of yet other glycosyltransferases, the same approach could obviously also be chosen for other glyco-determinants. In addition to antibody binding, the reactivity with animal lectins could be studied with such transferrin glycoforms using Western blot, ELISA or immunohistochemistry with transferrin specific antibodies. Indeed, a Drosophila lectin binding core α1,3-fucose has been characterised using MMF-transferrin prepared in this laboratory (Bouyain et al., 2002) .
In this study the specificity of polyclonal rabbit sera, especially of an anti-HRP serum and of a rodent monoclonal antibody were studied. The latter, YZ1/2.23, exhibited a somewhat complicated epitope structure where both the fucose and the xylose residue play a role for antibody binding. In contrast, anti-HRP appears to consist of two distinct populations with paratopes either binding fucosylated or xylosylated glycans.
Reflecting the absence of xylose in insect glycoproteins, the anti-honey bee serum only bound to core α1,3-fucosylated transferrin.
The results obtained for GnGnF and GnGnXF show that the mere presence of core α1,3-fucose is however not the only criterion for binding of these antibodies. The CCD-epitope can be hidden by additional modifications of the N-glycan as was already suggested as an explanation for the low anti-HRP binding of tree pollens which predominantly contain N-glycans with terminal GlcNAc residues (Wilson et al., 1998a; Wilson et al., 1998b; Wilson et al., 2001) .
Steric factors may also influence antibody binding. In Western blots, it appeared that the proteolytic fragment generated during enzymatic modifications of transferrin, binds slightly stronger than the full length transferrin (Fig. 4) . A similar, albeit contrary, observation is made with honeybee phospholipase as compared to the much less abundant hyaluronidase (Hemmer et al., 2003) . Unfortunately, such effects of steric presentation on antibody binding are difficult to discern experimentally.
Another modulator of binding strength beyond glycan structure is the valency of the glyco-antigen. We suggest that this valency factor explains the difference in inhibitory potency of MMXF-Tf and HRP. Polyvalency is an important factor for the ability to trigger physiological reactions of effector cells in allergy. As transferrin is divalent it can be expected to be effective in biological test systems such as histamine release by granulocytes.
The analysis of the specificity of patients` sera revealed -once again -the importance of core α1,3-linked fucose. This had to be expected in the bee and wasp venom reactive group but it was also observed for patients with oil seed rape and multiple pollen reactivity . Remarkably, however, MMXF-Tf consistently gave higher ELISA readings than MMF-Tf, even though no patient in our test groups exhibited significant binding with merely xylosylated glycans.
It should be emphasized that the bio-synthetic glyco-antigens used here are more reliable probes for anti-CCD IgE than e.g. honeybee phospholipase which also contains a number of highly important peptide epitopes. In the near future, larger numbers of patients` sera shall be analysed using the glycomodified transferrins with methods more suitable for IgE quantitation than ELISA. Apart from the maybe academic question whether there are xylose-reactive patients, a major issue will be to render allergy diagnosis more reliable by allowing discrimination between IgE binding to peptide or to carbohydrate epitopes. Although the overall prevalence of anti-CCD antibodies in our patients' sera was lower than that reported by others (Mari, 2002) , our data suggest that such antibodies may be commonly found in patients with multiple sensitization to many different allergens. However, there is no obvious correlation between anti-CCD titers as measured with, e.g., MMXF-Tf and total IgE levels ( Fig. 6B ) which contradicts the view that CCD-reactivity is merely a non-specific phenomenon observed in highly atopic patients.
Especially in the case of insect venom and food allergy, both including a certain risk for fatal or near-fatal reactions, it appears appropriate to develop tests which can result in reassuring patients where a positive laboratory result is merely caused by CCDs which supposedly have no clinical significance -at least in the absence of antipeptide IgE against the respective allergen.
METHODS
Enzymes, antibodies and other materials
Recombinant forms of Arabidopsis thaliana β1,2-xylosyltransferase and core α1,3-fucosyltransferase were expressed in Pichia pastoris and purified as recently described (Bencúrová et al., 2003) . The enzyme unit is defined as transfer of 1 µmol of xylose or fucose per min at 16 or 37°C, respectively, to a dabsylated or dansylated GnGn-tetrapeptide (Calbiochem) (Bencúrová et al., 2003) . β-Galactosidase from Aspergillus oryzae (Sigma-Aldrich) was purified before use (Zeleny et al., 1997) .
Neuraminidase from C. perfringens and α-mannosidase from jack bean were also obtained from Sigma Aldrich. β-N-acetyl-glucosaminidase from Streptococcus pneumoniae (Calbiochem) was used instead of the enzyme from jack bean as the latter contained plant N-glycan structures interfering with the objectives of this work.
Honeybee venom phospholipase was prepared as described and Helix pomatia hemocyanin was obtained from Serva (Heidelberg, Germany).
GDP-fucose was purchased from Sigma-Aldrich and UDP-xylose was obtained from
CarboSource Services at the University of Georgia.
The monoclonal antibody YZ1/2.23, raised against elderberry abscission tissue, was a gift of Dr. Daphne Osborne (Open University) and David Ashford (University of York). Polyclonal anti-horseradish peroxidase serum from rabbit, anti-bee venom serum from rabbit and the respective second antibodies have been described before (McManus et al., 1988; Wilson et al., 1998a) . Sera were collected from patients undergoing routine allergy testing for inhalant or insect venom allergy. Patients with inhalant allergy were skin prick tested with common inhalant allergens including pollens (hazel, alder, birch, grass, rye, ash, plantain, nettle, mugwort, ragweed, oilseed rape, plane tree), house dust mites, animal danders (cat, dog, horse, guinea pig), molds (Cladosporium, Alternaria, Penicillium), and rubber latex (all Soluprick, ALK, Denmark).
Insect venom allergy was confirmed by positive radioallergosorbent test and subsequent skin testing.
Three groups of sera were used: (1) Sera from patients suffering from pollen allergy which according to radioallergosorbent and skin prick test were sensitized to a narrow range of pollen allergens only, i.e. birch and other Fagales pollen only (n=20) and grass/rye pollen only (n=24); all patients from this group also had a positive radioallergosorbent test to the respective allergen; four of the 44 patients had a weakly positive skin test but negative serology to one of the tested indoor allergens; (2) sera from patients with multiple pollen sensitization, i.e. sensitization to at least four different pollen species (n=41); patients from this group had multiple positive radioallergosorbent test to pollen allergens although not all allergens reacting positively in the skin test have been tested by serology; 26 of the patients were also sensitized to one or more of the indoor allergens; (3) preselected sera which were assumed to contain anti-CCD IgE such as those reacting with HMW glycoallergens in oilseed rape pollen (Focke et al., 1988) (n=9) or those exhibiting cross-reactivity with bee and wasp venom glycoallergens (Hemmer et al., 2001; Hemmer et al., submitted) (n=7) .
Preparation of glyco-modified transferrins
10 mg of human apo-transferrin (Sigma-Aldrich) was treated for 16 h with 100 mU of neuraminidase in 0.5 mL of 50 mM sodium acetate buffer at pH 5.0 at 37 o C.
Subsequently, 4.2 U of β-galactosidase from Aspergillus oryzae (Zeleny et al., 1997) was added and the sample was incubated overnight. The integrity of the resultant GnGn-transferrin was checked by SDS-PAGE and the N-glycans were analysed as described below.
For xylosylation, GnGn-transferrin (5 mg in a final volume of 1.6 mL) was incubated with 4 µmol UDP-xylose and 13 mU of Xyl-T (in 25 mM 2(Nmorpholino)ethanesulfonic acid, pH 7.0) at 16 o C for 48 h. For fucosylation, GnGntransferrin (2 mg in a final volume of 0.8 mL containing 20 mM MnCl 2 ) was incubated with 2.8 µmol of GDP-fucose (added in three aliquots over time) and 0.6 mU of Fuc-T (dissolved in 25 mM 2(N-morpholino)ethanesulfonic acid, pH 6.8) at 25°C for 48 h. A doubly modified glycoform, GnGnXF-transferrin, was obtained by fucosylation of GnGnX-transferrin.
In order to remove the terminal N-acetylglucosamine residues, solutions of GnGn-, GnGnX-, GnGnF-, and GnGnXF-transferrins were diluted threefold with 50 mM sodium citrate buffer of pH 5.0 and digested with β-N-acetyl-glucosaminidase (0.5 mU / mg of transferrin). For the preparation of glycoforms lacking the α1,3-mannosyl residue, 0.45 mg of MM-and MMX-transferrin were digested for 24 h at 37°C with 20 mU of jack bean α-mannosidase in the above buffer containing 0.1 mM ZnCl 2.
Analytical methods
The structures of the N-glycans on the various transferrin glycoforms were verified in two ways.
(1) In the first approach, 10 µg of glycoproteins were digested for 4 h at 37 o C with 0.5 µg of pepsin (Sigma-Aldrich) in 30 µL of 5 % formic acid. Then, this solvent was evaporated and the samples were deglycosylated with peptide:Nglyosidase A described . Oligosaccharides were isolated and analysed by MALDI mass spectrometry on a linear time-of-flight instrument as described . (2) Alternatively, glycoproteins were subjected to SDS-PAGE and bands were excised, S-alkylated and digested with described Katayama et al., 2001) . The (glyco-)peptides were analyzed by MALDI mass spectrometry on a Waters-Micromass Q-TOF GLOBAL system using α-cyano-4-hydroxycinnamic acid as the matrix.
Western blot
Transferrin glycoforms (0.1 µg) were separated by SDS polyacrylamide gel electrophoresis and electroblotted to nitrocellulose membrane. The membrane was blocked with 3 % non-fat milk in 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1 % Tween and subsequently incubated for 1 h with rabbit anti-horseradish peroxidase 
IgG ELISA
Transferrin glycoforms at a concentration of 5 µg/mL or oilseed rape pollen extract (OSR) at a protein concentration of 1 µg/mL was used for coating ELISA well plates (Nunc maxisorp) for 1 h at 37 o C in 0.1 M sodium carbonate buffer, pH 9.6. After the washing and blocking steps, plates were incubated for 1 h at 37 o C with either anti-HRP diluted 1:20,000 or YZ1/2.23 diluted 1: 40,000. The subsequent steps were performed as described previously (Wilson et al., 2001) .
For inhibition ELISA, sera were pre-incubated for 1 h at 37 °C with different glycoproteins at different concentrations.
IgE ELISA
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